Evidence map›Paper›PMID 30585249›Full record

ReviewMedicines (Basel, Switzerland)2018

Recent Progress of Basic Studies of Natural Products and Their Dental Application.

Hiroshi Sakagami, Taihei Watanabe, Tomonori Hoshino, Naoto Suda, Kazumasa Mori, Toshikazu Yasui, Naoki Yamauchi, Harutsugu Kashiwagi, Tsuneaki Gomi, Takaaki Oizumi and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Medicines (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 34 citations in OpenAlex.

  1. Inhibition ofPathogens (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Hiroshi SakagamiMeikai University Research Institute of Odontology (M-RIO), 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan. sakagami@dent.meikai.ac.jp.
Taihei WatanabeDivision of Pediatric Dentistry, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan. taiheidental10627@gmail.com.
Tomonori HoshinoDivision of Pediatric Dentistry, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan. thoshino1@dent.meikai.ac.jp.
Naoto SudaDivision of Orthodontics, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan. n-suda@dent.meikai.ac.jp.
Kazumasa MoriDivision of First Oral and Maxillofacial Surgery, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan. kazu-mori@dent.meikai.ac.jp.
Toshikazu YasuiDivision of Oral Health, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan. yasui@dent.meikai.ac.jp.
Naoki YamauchiMasuko Memorial Hospital, 35-28 Takehashi-cho, Nakamura-ku, Nagoya 453-8566, Japan. yamauchi@masuko.or.jp.
Harutsugu KashiwagiEcopale Co., Ltd., 885 Minamiisshiki, Nagaizumi-cho, Suntou-gun, Shizuoka 411-0932, Japan. ecopale@fujibamboogarden.com.
Tsuneaki GomiGomi clinic, 1-10-12 Hyakunin-cho, Shinjuku-ku, Tokyo 169-0073, Japan. fwkz9633@mb.infoweb.ne.jp.
Takaaki OizumiDaiwa Biological Research Institute Co., Ltd., 3-2-1 Sakado, Takatsu-ku, Kawasaki, Kanagawa 213-0012, Japan. takaakio@daiwaseibutsu.co.jp.
Junko NagaiDepartment of Medical Molecular Informatics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan. nagai-j@my-pharm.ac.jp.ORCID 0000-0002-9069-5752
Yoshihiro UesawaDepartment of Medical Molecular Informatics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan. uesawa@my-pharm.ac.jp.ORCID 0000-0002-5773-991X
Koichi TakaoDepartment of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Saitama 350-0295, Japan. ktakao@josai.ac.jp.
Yoshiaki SugitaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Saitama 350-0295, Japan. sugita@josai.ac.jp.
Meikai University · JPJosai University · JPMeiji Pharmaceutical University · JPNagoya Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present article reviews the research progress of three major polyphenols (tannins, flavonoids and lignin carbohydrate complexes), chromone (backbone structure of flavonoids) and herbal extracts. Chemical modified chromone derivatives showed highly specific toxicity against human oral squamous cell carcinoma cell lines, with much lower toxicity against human oral keratinocytes, as compared with various anticancer drugs. QSAR analysis suggests the possible correlation between their tumor-specificity and three-dimensional molecular shape. Condensed tannins in the tea extracts inactivated the glucosyltransferase enzymes, involved in the biofilm formation. Lignin-carbohydrate complexes (prepared by alkaline extraction and acid-precipitation) and crude alkaline extract of the leaves of

Indexed as

alkaline extractangiotensin II blockerchromonedental applicationglucosyltransferaseKampo medicinelignin-carbohydrate complexoral diseasespolyphenolQSAR analysis

Identifiers

PMID30585249
PMCPMC6473826
OpenAlexW2905677291

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.